Clinical Trial Update: Phase 4 IOP Signals Associated With ILUVIEN® [Phase 4]

View source ↗

Summary

Phase 4 trial update for ILUVIEN® signals associated with intraocular pressure (IOP) in diabetic macular edema patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• ILUVIEN (fluocinolone acetonide)

Snippet

Sponsor: Alimera Sciences | Conditions: Diabetic Macular Edema (DME) | Phase 4 | Status: COMPLETED